1-3 of 3
David D. Smith, PhD
Close
Sort by
Journal Articles

A Multi-Center Phase 1b, Open-Label, Dose-Finding Pilot Study to Evaluate the Combination of Carfilzomib and Cyclophosphamide with Dexamethasone (CCyD) Prior to Autologous Stem Cell Transplant (ASCT) in Patients with Transplant Eligible Newly Diagnosed Multiple Myeloma

William I. Bensinger, MD, Robert Vescio, MD, Cristina Gasparetto, MD, Elber S. Camacho, MD, Rajneesh Nath, MD, Christina L. Gomes, MD, David D. Smith, PhD, Jatin J. Shah, Brian G. M. Durie, MD
Journal: Blood
Blood (2014) 124 (21): 4739.
https://doi.org/10.1182/blood.V124.21.4739.4739
Published: 2014
Journal Articles

A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Adam D. Cohen, MD, Emma C. Scott, MD, Michaela Liedtke, MD, Jonathan L. Kaufman, MD, Heather Landau, MD, David H. Vesole, MD PhD, Christina L. Gomes, MD, Cristina Gasparetto, MD, Suzanne Lentzsch, MD PhD, Michael Rosenzweig, MD, Vaishali Sanchorawala, MD, David D. Smith, PhD, Raymond L. Comenzo, MD, Brian G. M. Durie, MD
Journal: Blood
Blood (2014) 124 (21): 4741.
https://doi.org/10.1182/blood.V124.21.4741.4741
Published: 2014
Journal Articles

Phase I/II Dose Expansion Of a Multi-Center Trial Of Carfilzomib and Pomalidomide With Dexamethasone (Car-Pom-d) In Patients With Relapsed/Refractory Multiple Myeloma

Jatin J. Shah, M.D., Edward A. Stadtmauer, MD, Rafat Abonour, MD, Adam D. Cohen, MD, William Bensinger, MD, Cristina Gasparetto, MD, Jonathan L. Kaufman, MD, Suzanne Lentzsch, MD, PhD, Dan T. Vogl, MD, MSCE, Robert Z. Orlowski, M.D., Ph.D., Erica L. Kim, MPH, Natalia Bialas, David D. Smith, PhD, Brian GM Durie, MD
Journal: Blood
Blood (2013) 122 (21): 690.
https://doi.org/10.1182/blood.V122.21.690.690
Published: 2013